Detalhe da pesquisa
1.
Incretin and glucagon receptor polypharmacology in chronic kidney disease.
Am J Physiol Endocrinol Metab
; 326(6): E747-E766, 2024 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38477666
2.
Unbiased kidney-centric molecular categorization of chronic kidney disease as a step towards precision medicine.
Kidney Int
; 105(6): 1263-1278, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38286178
3.
Different roles of protein biomarkers predicting eGFR trajectories in people with chronic kidney disease and diabetes mellitus: a nationwide retrospective cohort study.
Cardiovasc Diabetol
; 22(1): 74, 2023 03 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-36991445
4.
Indicators of Kidney Fibrosis in Patients with Type 2 Diabetes and Chronic Kidney Disease Treated with Dulaglutide.
Am J Nephrol
; 54(1-2): 74-82, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36754023
5.
Results of untargeted analysis using the SOMAscan proteomics platform indicates novel associations of circulating proteins with risk of progression to kidney failure in diabetes.
Kidney Int
; 102(2): 370-381, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35618095
6.
The dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist tirzepatide improves cardiovascular risk biomarkers in patients with type 2 diabetes: A post hoc analysis.
Diabetes Obes Metab
; 24(1): 148-153, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34542221
7.
Comprehensive Search for Novel Circulating miRNAs and Axon Guidance Pathway Proteins Associated with Risk of ESKD in Diabetes.
J Am Soc Nephrol
; 32(9): 2331-2351, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34140396
8.
A Sequential Algorithm Combining ADAPT and Liver Stiffness Can Stage Metabolic-Associated Fatty Liver Disease in Hospital-Based and Primary Care Patients.
Am J Gastroenterol
; 116(5): 984-993, 2021 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33252454
9.
The dual glucose-dependent insulinotropic peptide and glucagon-like peptide-1 receptor agonist, tirzepatide, improves lipoprotein biomarkers associated with insulin resistance and cardiovascular risk in patients with type 2 diabetes.
Diabetes Obes Metab
; 22(12): 2451-2459, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33462955
10.
Associations of osteopontin and NT-proBNP with circulating miRNA levels in acute coronary syndrome.
Physiol Genomics
; 51(10): 506-515, 2019 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31530226
11.
Integrative analysis of prognostic biomarkers derived from multiomics panels helps discrimination of chronic kidney disease trajectories in people with type 2 diabetes.
Kidney Int
; 96(6): 1381-1388, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31679767
12.
Markers of early progressive renal decline in type 2 diabetes suggest different implications for etiological studies and prognostic tests development.
Kidney Int
; 93(5): 1198-1206, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29398132
13.
JAK1/JAK2 inhibition by baricitinib in diabetic kidney disease: results from a Phase 2 randomized controlled clinical trial.
Nephrol Dial Transplant
; 33(11): 1950-1959, 2018 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29481660
14.
Improved clinical trial enrollment criterion to identify patients with diabetes at risk of end-stage renal disease.
Kidney Int
; 92(1): 258-266, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28396115
15.
A prospective study of multiple protein biomarkers to predict progression in diabetic chronic kidney disease.
Nephrol Dial Transplant
; 29(12): 2293-302, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25085239
16.
Biomarker Changes Associated With Both Dulaglutide and Cardiovascular Events in the REWIND Randomized Controlled Trial: A Nested Case-Control Post Hoc Analysis.
Diabetes Care
; 46(5): 1046-1051, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36897834
17.
Effects of Tirzepatide Versus Insulin Glargine on Cystatin C-Based Kidney Function: A SURPASS-4 Post Hoc Analysis.
Diabetes Care
; 46(8): 1501-1506, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37267479
18.
Clinical evaluation of a matrix metalloproteinase-12 cleaved fragment of titin as a cardiovascular serological biomarker.
J Transl Med
; 10: 140, 2012 Jul 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-22768802
19.
Effects of Tirzepatide, a Dual GIP and GLP-1 RA, on Lipid and Metabolite Profiles in Subjects With Type 2 Diabetes.
J Clin Endocrinol Metab
; 107(2): 363-378, 2022 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34608929
20.
Effects of tirzepatide versus insulin glargine on kidney outcomes in type 2 diabetes in the SURPASS-4 trial: post-hoc analysis of an open-label, randomised, phase 3 trial.
Lancet Diabetes Endocrinol
; 10(11): 774-785, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36152639